Calquence

Calquence

Basic Prescribing Info
Contents
Acalabrutinib
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EL02 - acalabrutinib ; Belongs to the class of Bruton's tyrosine kinase (BTK) inhibitors. Used in the treatment of cancer.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Already a member? Sign in